McCourt Marion bought REGN
June 3, 2024 · Form 4 insider transaction
McCourt Marion bought 1,138 shares of Regeneron Pharmaceuticals, Inc. at $372.46 per share, a transaction worth $423.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,138
Price
$372.46
Total value
$423.9K
InsiderMcCourt Marion
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 3, 2024
Filing dateJune 5, 2024
Shares owned after14,069
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024.